Pyxis Oncology
Amanda Facklam is a scientist currently working at Pyxis Oncology since June 2023. Previously, Amanda held a scientist position at Seeker Biologics from September 2022 to April 2023. Amanda's academic journey includes a Ph.D. in Bioengineering from the Massachusetts Institute of Technology, completed in August 2022, and a Bachelor of Science in Biomedical Engineering from Johns Hopkins University, awarded in 2015. Amanda's research experience includes serving as a Ph.D. student at MIT's Anderson and Langer Labs and as an undergraduate researcher in the Gerecht Lab at Johns Hopkins. Additionally, Amanda gained leadership experience as a PILOT Leader at PILOT Learning and completed a research internship at EPFL in the summer of 2014.
Pyxis Oncology
2 followers
Pyxis Oncology is advancing a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to help patients suffering from difficult-to-treat cancers.